Skip to content
10-Q

Quarterly Report

Immunome, Inc. IMNM

0001193125-25-269603

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 91.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 87.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 84.82M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.21M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.24M sh
Capex Q3 2025 · Sep 30, 2025 $5.69M
Capex Q3 2025 · Sep 30, 2024 $6.05M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$142.97M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$68.73M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $272.64M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $143.35M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $155.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $263.92M
Stockholders Equity Q3 2025 · Jun 30, 2025 $269.27M
Stockholders Equity Q3 2025 · Mar 31, 2025 $307.13M
Stockholders Equity Q3 2025 · Dec 31, 2024 $181.17M
Stockholders Equity Q3 2025 · Sep 30, 2024 $214.91M
Stockholders Equity Q3 2025 · Jun 30, 2024 $253.84M
Stockholders Equity Q3 2025 · Mar 31, 2024 $285.57M
Stockholders Equity Q3 2025 · Dec 31, 2023 $119.88M
Current Liabilities Q3 2025 · Sep 30, 2025 $31.45M
Current Liabilities Q3 2025 · Dec 31, 2024 $54.31M
Total Liabilities Q3 2025 · Sep 30, 2025 $35.46M
Total Liabilities Q3 2025 · Dec 31, 2024 $59.08M
Current Assets Q3 2025 · Sep 30, 2025 $279.92M
Current Assets Q3 2025 · Dec 31, 2024 $221.34M
Total Assets Q3 2025 · Sep 30, 2025 $299.38M
Total Assets Q3 2025 · Dec 31, 2024 $240.24M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.65
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.68
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.78
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.72
Eps Basic Q3 2025 · Sep 30, 2025 −$0.65
Eps Basic Q3 2025 · Sep 30, 2025 −$1.68
Eps Basic Q3 2025 · Sep 30, 2024 −$0.78
Eps Basic Q3 2025 · Sep 30, 2024 −$3.72
Sga Expense Q3 2025 · Sep 30, 2025 $10.95M
Sga Expense Q3 2025 · Sep 30, 2025 $31.68M
Sga Expense Q3 2025 · Sep 30, 2024 $9.53M
Sga Expense Q3 2025 · Sep 30, 2024 $22.51M
Rd Expense Q3 2025 · Sep 30, 2025 $49.19M
Rd Expense Q3 2025 · Sep 30, 2025 $126.52M
Rd Expense Q3 2025 · Sep 30, 2024 $37.2M
Rd Expense Q3 2025 · Sep 30, 2024 $81.65M
Net Income Q3 2025 · Sep 30, 2025 −$57.46M
Net Income Q3 2025 · Sep 30, 2025 −$142.49M
Net Income Q3 2025 · Jun 30, 2025 −$43.4M
Net Income Q3 2025 · Mar 31, 2025 −$41.64M
Net Income Q3 2025 · Sep 30, 2024 −$47.1M
Net Income Q3 2025 · Sep 30, 2024 −$212.71M
Net Income Q3 2025 · Jun 30, 2024 −$36.12M
Net Income Q3 2025 · Mar 31, 2024 −$129.49M
Operating Income Q3 2025 · Sep 30, 2025 −$60.14M
Operating Income Q3 2025 · Sep 30, 2025 −$151.25M
Operating Income Q3 2025 · Sep 30, 2024 −$50.52M
Operating Income Q3 2025 · Sep 30, 2024 −$222.83M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $6.94M
Revenue Q3 2025 · Sep 30, 2024 $2.91M
Revenue Q3 2025 · Sep 30, 2024 $6.3M